Patents by Inventor Alice Marcy

Alice Marcy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF CANCER USING MEGLUMINE
    Publication number: 20190160084
    Abstract: Compositions and methods are disclosed for treating subjects with cancer, particularly skin cancer.
    Type: Application
    Filed: July 26, 2017
    Publication date: May 30, 2019
    Inventors: Annette TOBIA, Alice MARCY, Susan GILMOUR
  • Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
    Patent number: 9861593
    Abstract: Method for the treatment or prophylaxis of dry eye disorders by the administration of alkylamino-polyhydroxyalkanes and compositions thereof.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: January 9, 2018
    Assignee: Dynamis Pharmaceuticals, Inc.
    Inventors: Alice Marcy, Annette Tobia
  • METHOD FOR TREATING OR PREVENTING DRY EYE DISORDERS USING ALKYLAMINO-POLYHYDROXYALKANES
    Publication number: 20170049719
    Abstract: Method for the treatment or prophylaxis of dry eye disorders by the administration of alkylamino-polyhydroxyalkanes and compositions thereof.
    Type: Application
    Filed: November 7, 2016
    Publication date: February 23, 2017
    Inventors: Alice Marcy, Annette Tobia
  • NATURAL PRODUCT INHIBITORS OF 3DG
    Publication number: 20160331798
    Abstract: Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.
    Type: Application
    Filed: July 25, 2016
    Publication date: November 17, 2016
    Inventors: Annette Tobia, Alice Marcy, Bangying Su, Takeshi Niwa
  • Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
    Patent number: 9486418
    Abstract: Method for the treatment or prophylaxis of dry eye disorders by the administration of alkylamino-polyhydroxyalkanes and compositions thereof.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: November 8, 2016
    Assignee: Dynamis Pharmaceuticals, Inc.
    Inventors: Alice Marcy, Annette M. Tobia
  • NATURAL PRODUCT INHIBITORS OF 3DG
    Publication number: 20130266638
    Abstract: Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.
    Type: Application
    Filed: June 3, 2013
    Publication date: October 10, 2013
    Inventors: Annette Tobia, Alice Marcy, Bangying Su, Takeshi Niwa
  • METHOD FOR TREATING OR PREVENTING DRY EYE DISORDERS USING ALKYLAMINO-POLYHYDROXYALKANES
    Publication number: 20090253804
    Abstract: Method for the treatment or prophylaxis of dry eye disorders by the administration of alkylamino-polyhydroxyalkanes and compositions thereof.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 8, 2009
    Inventors: Alice Marcy, Annette M. Tobia
  • High throughput assay using fusion proteins
    Patent number: 5783398
    Abstract: This application describes a high throughput assay for screening for compounds capable of binding to a fusion protein which consists of a target protein and an FK506-binding protein. The method for preparing the DNA encoding for the fusion protein and for expressing that DNA is also described in the application. The invention also discloses the recombinant DNA and protein sequences for several fusion proteins.
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: July 21, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Alice Marcy, Scott P. Salowe, Douglas Wisniewski